2. Search Result
Search Result
Results for "

Cysltr1

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

2

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-13315S1
    Montelukast-d6 sodium

    MK0476-d6

    		 Leukotriene Receptor Inflammation/Immunology
    Montelukast-d6 (sodium) is the deuterium labeled Montelukast (sodium). Montelukast sodium is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (Cysltr1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage[1].
    Montelukast-d6 sodium
  • HY-RS03494
    CYSLTR1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others
    CYSLTR1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYSLTR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
    CYSLTR1 Human Pre-designed siRNA Set A
    CYSLTR1 Human Pre-designed siRNA Set A
  • HY-RS03495
    Cysltr1 Mouse Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others
    Cysltr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cysltr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Cysltr1 Mouse Pre-designed siRNA Set A
    Cysltr1 Mouse Pre-designed siRNA Set A
  • HY-RS03496
    Cysltr1 Rat Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others
    Cysltr1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cysltr1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Cysltr1 Rat Pre-designed siRNA Set A
    Cysltr1 Rat Pre-designed siRNA Set A
  • HY-13315S
    Montelukast-d6

    MK0476-d6 free acid

    		 Isotope-Labeled Compounds Leukotriene Receptor Inflammation/Immunology
    Montelukast-d6 is the deuterium labeled Montelukast (sodium). Montelukast sodium is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (Cysltr1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage[1].
    Montelukast-d6
  • HY-13315
    Montelukast sodium
    Maximum Cited Publications
    7 Publications Verification

    MK0476

    		 Leukotriene Receptor Inflammation/Immunology
    Montelukast sodium (MK0476) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast sodium decreases eosinophil infiltration into the asthmatic airways. Montelukast sodium can also be used for COVID-19 research [1] .
    Montelukast sodium
  • HY-13315A
    Montelukast
    Maximum Cited Publications
    7 Publications Verification

    MK0476 free base

    		 Leukotriene Receptor Inflammation/Immunology
    Montelukast (MK0476 free base) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast can be used for the reseach of asthma and liver injury. Montelukast also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast decreases eosinophil infiltration into the asthmatic airways. Montelukast can also be used for COVID-19 research [1] .
    Montelukast
  • HY-13315B
    Montelukast dicyclohexylamine

    MK0476 dicyclohexylamine

    		 Leukotriene Receptor Inflammation/Immunology
    Montelukast (MK0476) dicyclohexylamine is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast dicyclohexylamine can be used for the reseach of asthma and liver injury. Montelukast dicyclohexylamine also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast dicyclohexylamine decreases eosinophil infiltration into the asthmatic airways. Montelukast dicyclohexylamine can also be used for COVID-19 research [1] .
    Montelukast dicyclohexylamine

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: